Literature DB >> 8296948

Sedatives and hypnotics in Stockholm: social factors and kinds of use.

G Blennow1, A Romelsjö, H Leifman, A Leifman, G Karlsson.   

Abstract

OBJECTIVES: The aims of the study were (1) to estimate prevalence rates of current, regular, and long-term use of sedatives and hypnotics and the incidence of regular use in an urban population and (2) to study the association between such use of drugs and sociodemographic factors, symptoms of disease, and alcohol consumption.
METHODS: Data on drug use in a random sample of 6217 adults in Stockholm County were analyzed with logistic regression.
RESULTS: The prevalence rate for current use of sedatives or hypnotics was 12.8% among men and 18.6% among women; the rate for regular use was 3.7% among males and 4.7% among females. The odds ratio for current use increased with age and was higher among unemployed persons and disability pensioners, high consumers of alcohol, persons with an increased level of symptoms, and widows. More than 25% of the persons who had used sedatives or hypnotics during the previous 2 weeks were regular users 6 months later. For persons aged 25 through 64 years, the annual incidence rate was 1.8% among men and 2.7% among women.
CONCLUSIONS: The comparatively low incidence and high prevalence of regular use implies that long-term use of sedatives and hypnotics is common.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8296948      PMCID: PMC1615006          DOI: 10.2105/ajph.84.2.242

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  21 in total

1.  Patterns of benzodiazepine use in Great Britain as measured by a general population survey.

Authors:  G C Dunbar; M H Perera; F A Jenner
Journal:  Br J Psychiatry       Date:  1989-12       Impact factor: 9.319

2.  Tranquillisers: prevalence, predictors and possible consequences. Data from a large United Kingdom survey.

Authors:  H Ashton; J F Golding
Journal:  Br J Addict       Date:  1989-05

3.  Secondary morbidity among the recently bereaved.

Authors:  V Mor; C McHorney; S Sherwood
Journal:  Am J Psychiatry       Date:  1986-02       Impact factor: 18.112

4.  Gradual withdrawal of diazepam after long-term therapy.

Authors:  P Tyrer; R Owen; S Dawling
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

Review 5.  Dependence on benzodiazepines.

Authors:  M Lader
Journal:  J Clin Psychiatry       Date:  1983-04       Impact factor: 4.384

Review 6.  Abuse liability of benzodiazepines.

Authors:  J H Woods; J L Katz; G Winger
Journal:  Pharmacol Rev       Date:  1987-12       Impact factor: 25.468

Review 7.  Benzodiazepine dependence.

Authors:  H Petursson; M H Lader
Journal:  Br J Addict       Date:  1981

8.  Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community.

Authors:  M Swartz; R Landerman; L K George; M L Melville; D Blazer; K Smith
Journal:  Am J Public Health       Date:  1991-05       Impact factor: 9.308

9.  Benzodiazepine tranquilizers and the risk of accidental injury.

Authors:  G Oster; D M Huse; S F Adams; J Imbimbo; M W Russell
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

10.  Psychotropic drug use by women: demographic, lifestyle, and personality correlates.

Authors:  R L Marinier; R O Pihl; C Wilford; J E Lapp
Journal:  Drug Intell Clin Pharm       Date:  1985-01
View more
  8 in total

1.  Utilization of hypnotic medication in the context of cancer: predictors and frequency of use.

Authors:  Lucie Casault; Josée Savard; Hans Ivers; Marie-Hélène Savard; Sébastien Simard
Journal:  Support Care Cancer       Date:  2011-06-03       Impact factor: 3.603

2.  Patterns of psychotropic medicine use and related diseases across educational groups: national cross-sectional survey.

Authors:  Merete W Nielsen; Ebba Holme Hansen; Niels Kristian Rasmussen
Journal:  Eur J Clin Pharmacol       Date:  2004-03-16       Impact factor: 2.953

3.  How a novel programme for increasing awareness of health professionals resulted in a 14% decrease in patients using excessive doses of psychotropic drugs in western France.

Authors:  C Victorri-Vigneau; G Basset; P Jolliet
Journal:  Eur J Clin Pharmacol       Date:  2006-02-28       Impact factor: 2.953

Review 4.  Women in clinical drug trials. An update.

Authors:  D L Schmucker; M S O'Mahony; E S Vesell
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

5.  Prevalence of and factors related to the use of antidepressants and benzodiazepines: results from the Singapore Mental Health Study.

Authors:  Mythily Subramaniam; Vincent Y F He; Janhavi A Vaingankar; Edimansyah Abdin; Siow Ann Chong
Journal:  BMC Psychiatry       Date:  2013-09-23       Impact factor: 3.630

6.  Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment.

Authors:  Yasushi Kawamata; Norio Sugawara; Masamichi Ishioka; Kazutoshi Kubo; Katsuji Suzuki; Akira Fujii; Hanako Furukori; Taku Nakagami; Norio Yasui-Furukori; Kazutaka Shimoda
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-15       Impact factor: 2.570

7.  Use of alcohol and drugs with addiction potential among older women and men in a population-based study. The Nord-Trøndelag Health Study 2006-2008 (HUNT3).

Authors:  Kjerstin Tevik; Geir Selbæk; Knut Engedal; Arnfinn Seim; Steinar Krokstad; Anne-S Helvik
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

8.  Concomitant alcohol and sedative-hypnotic drug use among the elderly in Norway.

Authors:  Elin Kristin Bye; Ingeborg Rossow
Journal:  Nordisk Alkohol Nark       Date:  2017-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.